We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About National Institutes of Health Stock

Invest in or calculate the value of your shares in National Institutes of Health or other pre-IPO companies through EquityZen's platform.

Get Started

National Institutes of Health Stock (NIOH)

National Institutes of Health is a biomedical research facility in the United States that focuses on biomedical and health-related research.

About National Institutes of Health Stock

Founded

1887

Headquarters

Bethesda, MD, US

Industries

Software, Artificial Intelligence, Data and Analytics

National Institutes of Health is a biomedical research facility in the United States. It is affiliated to the United States Department of Health and Human Services. It is the primary agency of the United States government responsible for biomedical and health-related research. It conducts its own scientific research through its Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program. National Institutes of Health has 1,200 principal investigators and more than 4,000 postdoctoral fellows in basic, translational, and clinical research. It comprises 27 separate institutes and centers that conduct research in different disciplines of biomedical science. With scientific accomplishments such as the discovery of fluoride to prevent tooth decay, the use of lithium to manage bipolar disorder, the creation of vaccines against hepatitis, Haemophilus influenzae (HIB) and human papillomavirus, National Institutes of Health has many agencies under its control. National Institutes of Health was established in 1887. It is based in Bethesda, Maryland.

National Institutes of Health Press Mentions

Stay in the know about the latest news on National Institutes of Health

National Institutes of Health Management

Leadership team at National Institutes of Health

Chief

Jose Galvez

Head - Molecular Genetics & Carcinogenesis Section

Curtis Harris

Locked Features

Join now and verify your accreditation status to gain access to:

  • National Institutes of Health current valuation
  • National Institutes of Health stock price
  • Available deals in National Institutes of Health and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in National Institutes of Health stock?

Accredited investors can buy pre-IPO stock in companies like National Institutes of Health through EquityZen funds. These investments are made available by existing National Institutes of Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell National Institutes of Health stock?

Shareholders can sell their National Institutes of Health stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."